Taken together, these findings would suggest that the loss of p16 tumor suppressor proteins in NPC may confer resistance to radiotherapy and may be associated with higher rate of failure after therapy with radiation +/- chemotherapy. This evidence concerns the gene TCHP and nasopharyngeal carcinoma.